Trials / Not Yet Recruiting
Not Yet RecruitingNCT06118463
Study on AUNIP as a Novel Tumor Marker for Cervical Cancer
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Lin Yuan · Academic / Other
- Sex
- Female
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
To detect the expression of AUNIP in cervical cancer serum, and to clarify its diagnostic and prognostic value.
Detailed description
Blood of all study participants of cervical cancer patients are collected to detect the expression of AUNIP, analyze the statistical correlation between the expression of cervical cancer AUNIP and clinicopathological parameters of patients, and preliminarily understand the expression of AUNIP in cervical cancer tumor tissues and its clinical diagnostic and progniostic value.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Detection of serum AUNIP expression | The experiment is carried out according to the ELISA kit instructions, and the absorbance optic density (OD) value of the enzyme labeler at 450 nm is read. The protein concentration of AUNIP in the serum sample is calculated according to the standard curve. |
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2027-10-01
- Completion
- 2029-01-01
- First posted
- 2023-11-07
- Last updated
- 2023-11-09
Source: ClinicalTrials.gov record NCT06118463. Inclusion in this directory is not an endorsement.